0.4962
price down icon3.65%   -0.0188
after-market Handel nachbörslich: .52 0.0238 +4.80%
loading

Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.66%
3.9432
4.1796 4.2484 3.4953 4.4552
Operating Income/Loss
5.66%
-3.9432
-4.1796 -4.2484 -3.4953 -4.4552
Nonoperating Income/Loss
22.78%
0.1366
0.1769 0.326 0.2502 0.2019
Income/Loss From Continuing Operations Before Tax
4.84%
-3.8067
-4.0003 -3.9224 -3.2451 -4.2532
Income/Loss From Continuing Operations After Tax
4.90%
-3.8067
-4.0028 -3.9224 -3.2451 -4.2532
Net Income/Loss
4.90%
-3.8067
-4.0028 -3.9224 -3.2451 -4.2532
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8.4424
- 8.401 8.401 8.401
Diluted Average Shares
8.4424
- 8.401 8.401 -
Basic Earnings Per Share
4.26%
-0.45
-0.47 -0.47 -0.39 -0.51
Diluted Earnings Per Share
4.26%
-0.45
-0.47 -0.47 -0.39 -0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Kapitalisierung:     |  Volumen (24h):